IPO Season Gains Intensity: Investors Baffled by Three Issues Opening on December 11

Mumbai, Dec 8 (Daily Alayaran.com): In a month marked by an influx of Initial Public Offerings (IPOs), Dalal Street witnessed a perfect storm of three issues kicking off simultaneously, leaving investors with limited funds and multiple investment options to consider.

Vishal Mega Mart, One Mobikwik System, and Sai Life Sciences are the three companies that will see their shares listed on the bourses on December 11. Each catering to different sectors - retail chain, fintech, and pharma industry - these issues offer varied value propositions to investors. With a combined capital raising of Rs 11,615 crore, these IPOs present an attractive offering for long-term gains.

According to experts from Anand Rathi Shares and Stock Brokers, Mobikwik (fintech) and Vishal Mega Mart (retail chain) have the potential to grow at a decent pace over time. Given that Mobikwik is a fintech platform, it can scale faster compared to other companies in its sector.

However, the analysts from Anand Rathi has an "avoid" rating for Sai Life Sciences due to concerns about its high valuation relative to peers.

According to experts from Swastika Investmart and StoxBox, investors should consider various factors - market positioning, growth potential, financial performance, before deciding which company to invest in. According to these experts, Vishal Mega Mart stands out due to its profitable business model and low organic retail penetration, making it a compelling investment choice.

On the other hand, One Mobikwik Systems, with its high grey market premium (GMP), seems to hold strong growth potential for investors.

In an exclusive interaction, Mahesh M Ojha, AVP Research at Hensex Securities stated that Vishal Mega Mart offers best potential for long-term gains followed by Mobikwik System.